Of course drugs with SAE and low efficacy have never been approved in the past (koff, koff). It could ONLY happen under Trump, right?
Try telling the thousands of patients and their families waiting with hope where previously there was no hope “you’re going to have to wait longer.” Or “well, it’s the only drug that could help you, but the FDA won’t allow it because there is an “x”% risk of a SAE.”
They’ll tell you to go to hell.
- Forums
- ASX - By Stock
- PYC
- Ann: First Subject Dosed in PKD Clinical Trial
PYC
pyc therapeutics limited
Add to My Watchlist
0.40%
!
$1.27

Ann: First Subject Dosed in PKD Clinical Trial, page-28
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 1380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | 1.265 |
1 | 15000 | 1.260 |
1 | 12000 | 1.255 |
1 | 4000 | 1.225 |
1 | 20000 | 1.220 |
Price($) | Vol. | No. |
---|---|---|
1.290 | 25630 | 2 |
1.295 | 24500 | 1 |
1.300 | 59168 | 4 |
1.325 | 9001 | 1 |
1.330 | 20000 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online